OST
Open Science Tracker
Home
Search
Journals
Fields
Analytics
API
Research Papers
4 of 1604 papers
CSV
Excel
All Years
All Papers
High Transparency
Medium Transparency
Low Transparency
Search
Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluation.
Vatsan RS
;
Bross PF
;
Liu K
;
Theoret M
;
De Claro AR
;
Lu J
;
Helms W
;
Niland B
;
Husain SR
;
Puri RK.
J Immunother Cancer
(Unknown)
Published:
2013
1/6 Transparent
PMC
DOI
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti…
Morales-Kastresana A
;
Catalán E
;
Hervás-Stubbs S
;
Palazón A
;
Azpilikueta A
;
Bolaños E
;
Anel A
;
Pardo J
;
Melero I.
J Immunother Cancer
(Unknown)
Published:
2013
2/6 Transparent
Funding Declared
PMC
DOI
Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to…
Becker JT
;
McNeel DG.
J Immunother Cancer
(Unknown)
Published:
2013
2/6 Transparent
Funding Declared
PMC
DOI
Immune evasion in acute myeloid leukemia: current concepts and future directions.
Teague RM
;
Kline J.
J Immunother Cancer
(Unknown)
Published:
2013
PMC
DOI
Previous
63
64
65